The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II multicenter study of the chimeric monoclonal antibody NEO102 (N) in adults with refractory colorectal cancer (CC).
 
Muhammad Shaalan Beg
Consulting or Advisory Role - Celgene
Speakers' Bureau - Bayer/Onyx
Research Funding - Celgene; miRNA Therapeutics; Precision Biologics
 
Michael Morse
No Relationships to Disclose
 
Benjamin R. Tan
Research Funding - Bayer; Eisai; Exelixis; Lilly; Neogenix Oncology; Pfizer; Roche/Genentech; Xcovery
 
Richard D. Kim
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Lilly
Speakers' Bureau - Bristol-Myers Squibb; Sanofi
Research Funding - Bayer; Novartis
 
Elizabeth Poplin
No Relationships to Disclose
 
Nilofer Saba Azad
No Relationships to Disclose
 
Sharon Mavroukakis
Stock and Other Ownership Interests - Precision Biologics
Consulting or Advisory Role - Precision Biologics
 
Melony A. Beatson
Employment - Precision Biologics
Stock and Other Ownership Interests - Precision Biologics
 
Philip M. Arlen
Employment - Precision Biologics
Leadership - Precision Biologics
Stock and Other Ownership Interests - Precision Biologics
Travel, Accommodations, Expenses - Precision Biologics